Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/1433327
Intercell AG (ICLL) - Product Pipeline Analysis
Description:
Intercell AG (ICLL) - Product Pipeline Analysis
Summary
This report is a source for data, analysis and actionable intelligence on the Intercell AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Summary
This report is a source for data, analysis and actionable intelligence on the Intercell AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Contents:
List of Tables
List of Figures
Intercell AG - Business Description
Key Facts
Intercell AG - Major Products and Services
Intercell AG Pipeline Products by Equipment Type
Intercell AG Pipeline Products by Development Stage
Intercell AG Pipeline Products by Therapy Area
Intercell AG Pipeline Products by Trial Phase
Anthrax Vaccine Patch
Product Status
Product Description
Immunostimulant Patch-Influenza Vaccination
Product Status
Product Description
Travelers Diarrhea Vaccine Patch
Product Status
Product Description
Product Milestone
Travelers Diarrhea Vaccine Patch Clinical Trial
Intercell AG - Key Competitors
Intercell AG - Key Employees
Intercell AG - Key Employee Biographies
Intercell AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Nov 09, 2010: Intercell Reports Net Loss Of EUR27.8 Million For Q3 2010
Oct 04, 2010: Intercell Appoints Eric Frings As New Site Director Of Intercell Biomedical
Sep 30, 2010: Intercell Appoints Staph Bakali As Chief Business Officer
Aug 17, 2010: Intercell Reports Net Loss Of EUR8.3 Million For Q2 2010
May 11, 2010: Intercell Reports Net Loss Of EUR14.7 Million For Q1 2010
Mar 03, 2010: Intercell Q4 Revenues Up 6%
Jan 05, 2010: Intercell Initiates Efficacy Trial For TD Vaccine System In Asia
Dec 16, 2009: Intercell Provides Update On Phase II Vaccine Studies
Dec 14, 2009: Intercell, GSK To Develop, Commercialise Needle-Free Patch-Based Vaccines
Nov 09, 2009: Intercell Q3 2009 Net Loss Increases
Appendix
Methodology
About Us
Contact Us
Disclaimer
Companies Mentioned
GlycoVaxyn AG
AlphaVax, Inc.
Emergent BioSolutions Inc.
Celldex Therapeutics, Inc.
AlphaVax, Inc.
Emergent BioSolutions Inc.
Celldex Therapeutics, Inc.
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1582661
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Tuesday, May 21, 2013
9:17:11 AM
9:17:11 AM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
Intercell AG (ICLL) - Product Pipeline Analysis
Web Address
http://www.researchandmarkets.com/reports/1433327
Office Code
OC8DIQSQOOVOVQ
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price | Electronic - Single User |
|
EURO€ 576.00 |
|---|---|---|
| Electronic - Enterprisewide |
|
EURO€ 1,729.00 |
| Electronic - Site License |
|
EURO€ 1,153.00 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Tuesday, May 21, 2013
9:17:11 AM
9:17:11 AM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp